Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-105276
Filing Date
2024-10-02
Accepted
2024-10-02 10:53:47
Documents
3
Group Members
HEIGHTS CAPITAL MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2425379d1_sc13g.htm SC 13G 56119
2 EXHIBIT 99.I tm2425379d1_ex99-i.htm EX-99.I 4827
3 EXHIBIT 99.II tm2425379d1_ex99-ii.htm EX-99.II 4219
  Complete submission text file 0001104659-24-105276.txt   67140
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Subject) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50777 | Film No.: 241345743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8080
CVI Investments, Inc. (Filed by) CIK: 0001649553 (see all company filings)

EIN.: 981253664 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G